Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

United Therapeutics

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of United Therapeutics' 2013 cardiovasular sales performance.

Rare disease therapies head the ‘class of 2015’

Rare disease therapies head the ‘class of 2015’

have a treatment option in the form of Wellstat Therapeutics' Xuriden (uridine triacetate). ... USA. dinutuximab. Unituxin. neuroblastoma. anti-GD2 antibody. United Therapeutics. USA. elotuzumab. Empliciti.

FDA approvals hit 19-year high

FDA approvals hit 19-year high Orkambi (ivacaftor plus lumacaftor) and United Therapeutics' paediatric bran cancer therapy Unituxin (dinutuximab).

Actelion claims first approval for PAH therapy Uptravi

Actelion claims first approval for PAH therapy Uptravi Uptravi will compete in the US marketplace with another oral prostacyclin agonist - United Therapeutics' Orenitram (treprostinil) - and Actelion is banking that the data behind its new drug will allow it to

GSK earns expanded approval for Volibris in Europe

GSK earns expanded approval for Volibris in Europe s Adempas (riociguat) and United Therapeutics' Orenitram (trepostinil).

Gilead receives FDA approval for PAH combo

Gilead receives FDA approval for PAH combo Additionally there will be competition from Bayer's Adempas (riociguat), which was cleared by the FDA in 2013, and United Therapeutics' Remodulin (treprostinil).

1 2 3 4 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics